Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
5,930.00
-100.00 (-1.66%)
At close: Feb 13, 2026
Sinsin Pharmaceutical Market Cap
Sinsin Pharmaceutical has a market cap or net worth of 89.96 billion as of February 13, 2026. Its market cap has increased by 7.82% in one year.
Market Cap
89.96B
Enterprise Value
132.47B
Revenue
110.29B
Ranking
n/a
PE Ratio
13.85
Stock Price
5,930.00
Market Cap Chart
Since February 28, 2017, Sinsin Pharmaceutical's market cap has decreased from 121.67B to 89.96B, a decrease of -26.06%. That is a compound annual growth rate of -3.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 89.96B | 1.19% |
| Dec 30, 2025 | 88.90B | 7.92% |
| Dec 30, 2024 | 82.38B | -12.98% |
| Dec 28, 2023 | 94.66B | 11.83% |
| Dec 29, 2022 | 84.65B | -13.49% |
| Dec 30, 2021 | 97.85B | -29.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharos iBio | 112.24B |
| BL Pharmtech | 111.52B |
| H.PIO | 99.27B |
| Sam-A Pharm. | 98.45B |
| Ahn-Gook Pharmaceutical | 98.42B |
| Daehan Nupharm | 95.02B |
| Hwail Pharmaceutical | 90.95B |
| Polaris AI Pharma | 85.81B |